AlzeCure Pharma (Sweden) Probability of Future Stock Price Finishing Under 1.79
| ALZCUR Stock | SEK 2.25 0.02 0.88% |
AlzeCure |
AlzeCure Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AlzeCure Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AlzeCure Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AlzeCure Pharma is way too risky over 90 days horizon | |
| AlzeCure Pharma appears to be risky and price may revert if volatility continues | |
| AlzeCure Pharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (77.78 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| AlzeCure Pharma has accumulated about 222.05 M in cash with (70.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.88, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 41.0% of the company shares are held by company insiders |
AlzeCure Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AlzeCure Stock often depends not only on the future outlook of the current and potential AlzeCure Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AlzeCure Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 39.3 M | |
| Cash And Short Term Investments | 41.7 M |
AlzeCure Pharma Technical Analysis
AlzeCure Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. AlzeCure Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AlzeCure Pharma. In general, you should focus on analyzing AlzeCure Stock price patterns and their correlations with different microeconomic environments and drivers.
AlzeCure Pharma Predictive Forecast Models
AlzeCure Pharma's time-series forecasting models is one of many AlzeCure Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AlzeCure Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about AlzeCure Pharma
Checking the ongoing alerts about AlzeCure Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AlzeCure Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| AlzeCure Pharma is way too risky over 90 days horizon | |
| AlzeCure Pharma appears to be risky and price may revert if volatility continues | |
| AlzeCure Pharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (77.78 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| AlzeCure Pharma has accumulated about 222.05 M in cash with (70.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.88, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 41.0% of the company shares are held by company insiders |
Other Information on Investing in AlzeCure Stock
AlzeCure Pharma financial ratios help investors to determine whether AlzeCure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AlzeCure with respect to the benefits of owning AlzeCure Pharma security.